Furthermore, tumor angiogenesis and modulation of genes associated with angiogenesis were critically reduced in tumor tissues treated with NR4A1 shRNAs and selective minigenes (Ye et al., 2019; Chen et al., 2020). This evidence concerns the gene NR4A1 and neoplasm.